Table 2.
Postprandial serum insulin area under the curve (AUC) in healthy subjects after the ingestion of OGTT with a placebo capsules (Reference) or the OGTT with C. longa capsules.
| Insulin AUC (mU min/L) | ||
|---|---|---|
| Time | Reference | C. longa |
| 0-15 min | 169.2 ± 19.8 | 217.5 ± 37.7* |
| 0-30 min | 584.3 ± 61.2 | 838.1 ± 152.7* |
| 0-45 min | 1076.5 ± 111.4 | 1509.9 ± 252.2 |
| 0-60 min | 1521.7 ± 147.3 | 2021.0 ± 285.9 |
| 0-90 min | 2210.3 ± 215.5 | 2908.3 ± 353.0* |
| 0-120 min | 2749.5 ± 283.7 | 3570.9 ± 410.7* |
All values are means ± SEM, n = 14. Significant differences in serum insulin AUCs were evaluated with the Wilcoxon signed rank sum test. * = Significant difference between the responses to the OGTT with and without C. longa, P < 0.05.